- Pharmaceutical companies
- North America
- United States
- Regeneron Pharmaceuticals
Regeneron Pharmaceuticals in United States
Addresses:
-
777 Old Saw Mill River Road, Tarrytown, NY 10591
Web: https://www.regeneron.com
Phone: +1 914-847-7000
-
Sleepy Hollow Office
1 Rockwood Road Sleepy Hollow, NY 10591
Web: https://www.regeneron.com/
Phone: +1 914-847-7000
-
Basking Ridge Office
110 Allen Road Basking Ridge, NJ 07920
Web: https://www.regeneron.com/
Phone: +1 914-847-7000
-
Industrial Operations and Product Supply
81 Columbia Turnpike Rensselaer, NY 12144
Web: https://www.regeneron.com/
Phone: +1 518-488-6000
Other Regeneron Pharmaceuticals's locations around the world
Clinical Trials sponsored by Regeneron Pharmaceuticals
-
Regeneron PharmaceuticalsIkke rekrutterer endnu
-
Regeneron PharmaceuticalsRekruttering
-
Regeneron PharmaceuticalsRekrutteringRecidiverende/refraktært follikulært lymfom | Marginal zone lymfom (MZL)Korea, Republikken, Australien, Spanien, Malaysia, Frankrig, Taiwan, Italien, Polen, Forenede Stater, Thailand, Det Forenede Kongerige, Kalkun, Belgien, Tjekkiet
-
Regeneron PharmaceuticalsRekruttering
-
Regeneron PharmaceuticalsRekrutteringMedfødt høretab sekundært til bialleliske mutationer i Otoferlin-genet (OTOF) | Biallele mutationer i Gap Junction Beta 2 (GJB2) genet | Digene mutationer i GJB2/Gap Junction Beta 6 (GJB6) generForenede Stater
-
Regeneron PharmaceuticalsIkke rekrutterer endnuDiabetisk makulært ødem (DME) | Neovaskulær aldersrelateret makuladegeneration (nAMD)
-
Regeneron PharmaceuticalsRekrutteringB-celle non-Hodgkins lymfom (B-NHL)Forenede Stater, Det Forenede Kongerige
-
Regeneron PharmaceuticalsRekruttering
-
Regeneron PharmaceuticalsRekrutteringIkke-alkoholisk Steatohepatitis (NASH) | Metabolisk dysfunktion Associeret Steatohepatitis (MASH)Forenede Stater, Korea, Republikken, Puerto Rico, Japan
-
Regeneron PharmaceuticalsRegeneron PharmaceuticalsRekruttering
About Regeneron Pharmaceuticals
Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to seven FDA-approved treatments and numerous product candidates in development, all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye disease, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, infectious diseases, pain and rare diseases. Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite® technologies, such as VelocImmune® which produces optimized fully-human antibodies, and ambitious research initiatives such as the Regeneron Genetics Center®, which is conducting one of the largest genetics sequencing efforts in the world.